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Introduction
Mortality rate of Acinetobacter infections have increased
due to having multiple drug resistance and increasing of
incidence among nosocomial infection. Importance of
high mortality rate of this infections is once more
increased due to scantiness of choosing antibiotics of
treatment and difficulty of isolation.
Objectives
Distribution of Acinetobacter spp which were identified
in intensive care units (ICUs) and antimicrobial suscept-
ibility patterns of them have been investigated in this
study.
Methods
Acinetobacter infections which were isolated in ten ICUs
of GMMA in 2011 have been investigated retrospectively.
Results
69 Acinetobacter strains were isolated from samples of
64 patients who were hospitalized in ICUs. Acinetobac-
ter infections have became two times in five patients. 21
of patients were female, 43 of them were male and aver-
age age was 61,09±24,16 (2-91) years. Distributions of
Acinetobacter infectious of ICUs were investigated and
the most infectious (49,3% n:34) were occured at medi-
cal ICU followed by anesthesia recovery unit(20,3%
n:14), burn unit (8,7% n:6), ICU of general surgery unit
(7,2% n:5), ICU of neurology unit (5,8% n:4), respec-
tively. The avarage of interval between hospitalization
date and devolopment time of infectious was 27,78
±40,02 (3-282) days and it varies according to the differ-
ent ICUs Bloodstream infection was the most common
infection, followed by urinary tract infection, pneumonia
(n:10 14,4%), skin and soft tissue infections (n:8 11,6%),
respectively. The most common species was A. bau-
manni (n:45 65,2%) and A. calcoaceticus (n:3 4,3%) was
the second. When antimicrobial susceptibility patterns
of isolated acinetobacter spp were investigated, suscept-
ibility rates were determined as 100% to colistin, 27,2%
to tigecycline, 25% to amikacin, 19,1% to gentamicin,
18,4% to cotrimoxazole, 5,1% to ciprofloxacin, 4,4% to
piperacillin-tazobactam, 3,3% to aztreonam, 3,2% to
cefotaxime, 3,1% to ceftazidime, 1,4% to imipenem and
meropenem.
Conclusion
Number of Acinetobacter infections are increasing corra-
lated with the number of beds in ICUs. Isolation of
infected patients and obeying the rules of universal con-
tact isolation of health care personnel are important.
Resistance rate of tigecycline was increased in short




1Infectious Diseases and Clinical Microbiology, Gülhane Military Hospital,
Ankara, Turkey. 2Infection Control, Gülhane Military Hospital, Ankara, Turkey.
Published: 20 June 2013
doi:10.1186/2047-2994-2-S1-P234
Cite this article as: Gül et al.: P234: Acinetobacter infections in intensive
care units in 2011. Antimicrobial Resistance and Infection Control 2013
2(Suppl 1):P234.
1Infectious Diseases and Clinical Microbiology, Gülhane Military Hospital,
Ankara, Turkey
Full list of author information is available at the end of the article
Gül et al. Antimicrobial Resistance and Infection Control 2013, 2(Suppl 1):P234
http://www.aricjournal.com/content/2/S1/P234
© 2013 Gül et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
